AMPYRA
NDC 10144-427, Dalfampridine, tablet, film coated, extended release, from Merz Pharmaceuticals, LLC.
- Product NDC
- 10144-427
- Status
- Listed
- Labeler
- Merz Pharmaceuticals, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022250
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10144-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DALFAMPRIDINE10 mg/1
Pharmacologic classes
Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10144-427-60 | 10144042760 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10144-427-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783
Use it
Look up 10144-427 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10144-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10144-427. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.